Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.

× No keyword cloud information.

8 in total

1. Genetic CYP2C19 polymorphism dependent non-responders to clopidogrel therapy--does structural design, dosing and induction strategies have a role to play?

Authors: Nuggehally R Srinivas
Journal: Eur J Drug Metab Pharmacokinet Date: 2009 Jul-Sep Impact factor: 2.441

2. Impact of CYP2C19 polymorphisms on the clinical action of proton pump inhibitors (PPIs).

Authors: Ulrich Klotz
Journal: Eur J Clin Pharmacol Date: 2008-10-29 Impact factor: 2.953

Review 3. Thienopyridine therapy and risk for cardiovascular events in secondary prevention.

Authors: Peter P Toth; Annemarie Armani
Journal: Curr Atheroscler Rep Date: 2009-09 Impact factor: 5.113

4. Risk of adverse clinical outcomes with concomitant use of clopidogrel and proton pump inhibitors following percutaneous coronary intervention.

Authors: Ekta Gupta; Darpan Bansal; John Sotos; Kevin Olden
Journal: Dig Dis Sci Date: 2010-07 Impact factor: 3.199

5. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.

Authors: Yi-Wen Tsai; Yu-Wen Wen; Weng-Foung Huang; Pei-Fen Chen; Ken N Kuo; Fei-Yuan Hsiao
Journal: J Gastroenterol Date: 2010-09-02 Impact factor: 7.527

6. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.

Authors: Wayne A Ray; Katherine T Murray; Marie R Griffin; Cecilia P Chung; Walter E Smalley; Kathi Hall; James R Daugherty; Lisa A Kaltenbach; C Michael Stein
Journal: Ann Intern Med Date: 2010-03-16 Impact factor: 25.391

7. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.

Authors: Alan R Shuldiner; Jeffrey R O'Connell; Kevin P Bliden; Amish Gandhi; Kathleen Ryan; Richard B Horenstein; Coleen M Damcott; Ruth Pakyz; Udaya S Tantry; Quince Gibson; Toni I Pollin; Wendy Post; Afshin Parsa; Braxton D Mitchell; Nauder Faraday; William Herzog; Paul A Gurbel
Journal: JAMA Date: 2009-08-26 Impact factor: 56.272

Review 8. Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview.

Authors: William B Hillegass; Brigitta C Brott; James C Dobbs; Silvio E Papapietro; Vijay K Misra; Gilbert J Zoghbi
Journal: Vasc Health Risk Manag Date: 2011-07-18

8 in total